Palvella Therapeutics, Inc. (PVLA) Balance Sheet
As of 2026-06-30 (10-Q), Palvella Therapeutics, Inc. (PVLA) reported total assets of $253.5M, total liabilities of $36.6M and shareholders' equity of $216.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $187.8M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PVLAPalvella Therapeutics, Inc.Follow PVLA — free
—
Price chart with a free account
- Market cap
- 1.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 17 Nov, in 24 days
| Line | FY2014 Jun 14 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Jan 19 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.5 | 18.5 | 29.4 | 29.4 | 37.9 | 74.9 | 62.3 | 70.4 | 117.8 | 38.6 | 7.4 | 83.6 | 58.0 | 187.8 | |
| Short-term investments | — | — | — | 0.0 | 34.8 | 53.2 | 41.9 | 0.0 | 0.0 | 20.5 | 9.0 | — | 0.0 | 62.8 | |
| Receivables | — | 0.0 | 0.0 | 0.1 | 15.5 | 2.7 | 6.8 | 1.7 | 3.3 | 5.8 | 0.0 | 0.4 | 0.0 | — | |
| Current assets | 0.0 | 19.8 | 31.7 | 32.7 | 89.8 | 135.4 | 115.0 | 75.7 | 127.6 | 73.4 | 7.5 | 88.2 | 59.0 | 253.0 | |
| Total assets | 0.0 | 21.9 | 34.0 | 35.1 | 103.9 | 143.2 | 141.1 | 105.0 | 153.6 | 95.5 | 7.5 | 88.2 | 59.6 | 253.5 | |
| Current liabilities | 0.0 | 3.5 | 2.8 | 8.4 | 45.8 | 48.1 | 27.0 | 22.1 | 50.6 | 36.6 | 2.4 | 12.0 | 11.3 | 11.9 | |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | — | 18.4 | 18.4 | — | |
| Total liabilities | 0.0 | 3.9 | 2.8 | 9.8 | 92.4 | 104.9 | 89.7 | 74.0 | 102.8 | 67.6 | 11.4 | 25.6 | 31.6 | 36.6 | |
| Shareholders' equity | 0.0 | 18.0 | 31.1 | 25.2 | 11.5 | 38.3 | 51.4 | 31.0 | 50.8 | -93.8 | -74.5 | 62.6 | 28.0 | 216.9 |
USD millions · SEC XBRL
Palvella Therapeutics, Inc. — questions
- How much cash does Palvella Therapeutics, Inc. have?
- $187.8M in cash and cash equivalents as of 2026-06-30.
- What are Palvella Therapeutics, Inc.'s total assets?
- $253.5M as of 2026-06-30.
- What is Palvella Therapeutics, Inc.'s shareholders' equity?
- $216.9M as of 2026-06-30.
Every figure on this page comes from Palvella Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.